Uncategorized
Cost-effectiveness of general population screening for glaucoma unproven, difficult to evaluate
PRAGUE — Systematic screening has so far failed to prove cost-effective and to improve the management of glaucoma in clinical practice, according to one specialist speaking at the European Glaucoma Society Congress. If half of the glaucoma population in Western countries remains undiagnosed, systematic population screenings have led to over-referral, increasing the burden of false positives and overtreatment, Anja Tuulonen, MD, PhD, said.